These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 32727330)
1. Pharmacological Strategy for Congenital Myasthenic Syndrome with CHRNE Mutations: A Meta-Analysis of Case Reports. Huang K; Luo YB; Bi FF; Yang H Curr Neuropharmacol; 2021; 19(5):718-729. PubMed ID: 32727330 [TBL] [Abstract][Full Text] [Related]
2. Pharmacological Treatments for Congenital Myasthenic Syndromes Caused by Shao S; Shi G; Bi FF; Huang K Curr Neuropharmacol; 2023; 21(7):1594-1605. PubMed ID: 36703579 [TBL] [Abstract][Full Text] [Related]
3. A common CHRNE mutation in Brazilian patients with congenital myasthenic syndrome. Estephan EP; Sobreira CFDR; Dos Santos ACJ; Tomaselli PJ; Marques W; Ortega RPM; Costa MCM; da Silva AMS; Mendonça RH; Caldas VM; Zambon AA; Abath Neto O; Marchiori PE; Heise CO; Reed UC; Azuma Y; Töpf A; Lochmüller H; Zanoteli E J Neurol; 2018 Mar; 265(3):708-713. PubMed ID: 29383513 [TBL] [Abstract][Full Text] [Related]
4. A rare c.183_187dupCTCAC mutation of the acetylcholine receptor CHRNE gene in a South Asian female with congenital myasthenic syndrome: a case report. Chang T; Cossins J; Beeson D BMC Neurol; 2016 Oct; 16(1):195. PubMed ID: 27717316 [TBL] [Abstract][Full Text] [Related]
5. Congenital myasthenic syndrome in Turkey: clinical and genetic features in the long-term follow-up of patients. Gül Mert G; Özcan N; Hergüner Ö; Altunbaşak Ş; Incecik F; Bişgin A; Ceylaner S Acta Neurol Belg; 2021 Apr; 121(2):529-534. PubMed ID: 31773638 [TBL] [Abstract][Full Text] [Related]
6. CHRND mutation causes a congenital myasthenic syndrome by impairing co-clustering of the acetylcholine receptor with rapsyn. Müller JS; Baumeister SK; Schara U; Cossins J; Krause S; von der Hagen M; Huebner A; Webster R; Beeson D; Lochmüller H; Abicht A Brain; 2006 Oct; 129(Pt 10):2784-93. PubMed ID: 16916845 [TBL] [Abstract][Full Text] [Related]
7. Characterization of Clinical Phenotypes in Congenital Myasthenic Syndrome Associated with the c.1327delG Frameshift Mutation in CHRNE Encoding the Acetylcholine Receptor Epsilon Subunit. Kastreva K; Chamova T; Blagoeva S; Bichev S; Mihaylova V; Meyer S; Thompson R; Cherninkova S; Guergueltcheva V; Lochmuller H; Tournev I J Neuromuscul Dis; 2024; 11(5):1011-1020. PubMed ID: 38995797 [TBL] [Abstract][Full Text] [Related]
8. A CHRNE frameshift mutation causes congenital myasthenic syndrome in young Jack Russell Terriers. Rinz CJ; Lennon VA; James F; Thoreson JB; Tsai KL; Starr-Moss AN; Humphries HD; Guo LT; Palmer AC; Clark LA; Shelton GD Neuromuscul Disord; 2015 Dec; 25(12):921-7. PubMed ID: 26429099 [TBL] [Abstract][Full Text] [Related]
10. CHRNE compound heterozygous mutations in congenital myasthenic syndrome: A case report. Yang K; Cheng H; Yuan F; Meng L; Yin R; Zhang Y; Wang S; Wang C; Lu Y; Xi J; Lu Q; Chen Y Medicine (Baltimore); 2018 Apr; 97(17):e0347. PubMed ID: 29702980 [TBL] [Abstract][Full Text] [Related]
11. A synonymous CHRNE mutation responsible for an aberrant splicing leading to congenital myasthenic syndrome. Richard P; Gaudon K; Fournier E; Jackson C; Bauché S; Haddad H; Koenig J; Echenne B; Hantaï D; Eymard B Neuromuscul Disord; 2007 May; 17(5):409-14. PubMed ID: 17363247 [TBL] [Abstract][Full Text] [Related]
12. Congenital Myasthenic Syndrome associated with acetylcholine receptor deficiency: case report and review of the literature. Batheja A; Bayer-Vile J; Silverstein E; Couser N Ophthalmic Genet; 2024 Oct; 45(5):481-487. PubMed ID: 38832364 [TBL] [Abstract][Full Text] [Related]
13. Phenotypic heterogeneity in two large Roma families with a congenital myasthenic syndrome due to CHRNE 1267delG mutation. A long-term follow-up. Natera-de Benito D; Domínguez-Carral J; Muelas N; Nascimento A; Ortez C; Jaijo T; Arteaga R; Colomer J; Vilchez JJ Neuromuscul Disord; 2016 Nov; 26(11):789-795. PubMed ID: 27634344 [TBL] [Abstract][Full Text] [Related]
14. Calcitriol ameliorates motor deficits and prolongs survival of Chrne-deficient mouse, a model for congenital myasthenic syndrome, by inducing Rspo2. Ohkawara B; Tomita H; Inoue T; Zhang S; Kanbara S; Koshimizu H; Miyasaka Y; Takeda JI; Nishiwaki H; Nakashima H; Ito M; Masuda A; Ishiguro N; Ogi T; Ohno T; Imagama S; Ohno K Neurotherapeutics; 2024 Mar; 21(2):e00318. PubMed ID: 38233267 [TBL] [Abstract][Full Text] [Related]
15. Case Report: A Novel AChR Epsilon Variant Causing a Clinically Discordant Salbutamol Responsive Congenital Myasthenic Syndrome in Two Egyptian Siblings. Gómez-García de la Banda M; Simental-Aldaba E; Fahmy N; Sternberg D; Blondy P; Quijano-Roy S; Malfatti E Front Neurol; 2022; 13():909715. PubMed ID: 35720108 [TBL] [Abstract][Full Text] [Related]
17. Positive response to inhaled salbutamol in congenital myasthenic syndrome due to CHRNE mutation. Garg D; Goyal V Muscle Nerve; 2022 Jul; 66(1):E1-E2. PubMed ID: 35466404 [No Abstract] [Full Text] [Related]
18. Clinical and genetic characterization of an Italian family with slow-channel syndrome. Angelini C; Lispi L; Salvoro C; Mostacciuolo ML; Vazza G Neurol Sci; 2019 Mar; 40(3):503-507. PubMed ID: 30542963 [TBL] [Abstract][Full Text] [Related]
19. Congenital myasthenic syndrome in Japan: ethnically unique mutations in muscle nicotinic acetylcholine receptor subunits. Azuma Y; Nakata T; Tanaka M; Shen XM; Ito M; Iwata S; Okuno T; Nomura Y; Ando N; Ishigaki K; Ohkawara B; Masuda A; Natsume J; Kojima S; Sokabe M; Ohno K Neuromuscul Disord; 2015 Jan; 25(1):60-9. PubMed ID: 25264167 [TBL] [Abstract][Full Text] [Related]
20. Beneficial effect of albuterol in congenital myasthenic syndrome with epsilon-subunit mutations. Sadeh M; Shen XM; Engel AG Muscle Nerve; 2011 Aug; 44(2):289-91. PubMed ID: 21721016 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]